Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001007810 | SCV003786419 | uncertain significance | Bethlem myopathy 1A | 2022-01-03 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COL6A3 protein function. ClinVar contains an entry for this variant (Variation ID: 689566). This missense change has been observed in individual(s) with COL6A3-related conditions (PMID: 31230720). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 329 of the COL6A3 protein (p.Val329Met). |
Institute of Human Genetics, |
RCV000850319 | SCV000992494 | uncertain significance | Multiple joint contractures | no assertion criteria provided | clinical testing | ||
Lupski Lab, |
RCV001007810 | SCV001167501 | uncertain significance | Bethlem myopathy 1A | no assertion criteria provided | research |